The upcoming decision by the CDC’s Advisory Committee on Immunization Practices (ACIP) regarding the hepatitis B vaccine has sparked interest among scientists. The recommendation that all babies receive their first dose of the vaccine on their first day of life has been in place since 1991. This strategy has been highly effective in reducing infant infections by nearly eliminating them in the U.S. and decreasing infections in children by at least 90%. The ACIP had initially planned to vote on this matter at their September meeting but decided to delay the decision.
Epidemiologist and influenza expert Michael Osterholm and his colleagues are now conducting an independent review of the birth dose of the hepatitis B vaccine before the upcoming ACIP meeting. Despite the skepticism towards vaccination from some current ACIP members, Osterholm believes that it is crucial to review the evidence independently. This review aims to provide a comprehensive analysis of the data to ensure the best decision is made regarding the vaccine recommendation.
In other news, Ralph Abraham, Louisiana’s surgeon general, has been appointed as the principal deputy director at the CDC. This position is second only to the director of the agency. Abraham’s appointment has raised some concerns due to his views on vaccines. As a vaccine skeptic, Abraham has advocated for personal choice and consulting doctors regarding vaccinations. He has also expressed skepticism towards the COVID-19 vaccine and has favored natural immunity over vaccination.
Abraham’s stance on ivermectin, a controversial drug, has also raised eyebrows. He supported a bill to make ivermectin available over the counter in Louisiana. These views have led to criticism of his appointment, with some deeming it as irresponsible.
As Thanksgiving approaches, STAT reflects on past stories related to the holiday. From discussions about stretching one’s stomach before a feast to the dangers of football and changing Black Friday traditions, STAT has covered a range of Thanksgiving-related topics over the years. Additionally, the First Opinion Podcast delves into the ethics of animal research, specifically focusing on the use of beagles in scientific studies.
In the realm of healthcare news, recent developments include the Trump administration unveiling new Medicare-negotiated drug prices, the Trump EPA abandoning an air pollution rule, and major health insurers cutting broker commissions to avoid costly Medicare enrollees. These stories shed light on important issues impacting the healthcare industry.
Overall, the healthcare landscape continues to evolve, with ongoing debates and decisions shaping the future of public health and medicine. Stay informed with the latest updates and developments in the field.
